Radiotherapy for laryngeal cancers

J. Biau; Y. Pointreau; P. Blanchard; C. Khampan; P. Giraud; M. Lapeyre; P. Maingon

doi:10.1016/j.canrad.2021.09.004

Radiotherapy for laryngeal cancers

J. Biau, Y. Pointreau, P. Blanchard, C. Khampan, P. Giraud, M. Lapeyre, P. Maingon

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensity modulated radiotherapy is the standard of care radiotherapy for the management of laryngeal cancers. Early stage T1 or T2 tumours can be treated either by radiotherapy or conservative surgery. For tumours requiring total laryngectomy (T2 or T3), an organ preservation strategy by either induction chemotherapy followed by radiotherapy or chemoradiotherapy with cisplatin is recommended. For T4 tumours, a total laryngectomy followed by radiotherapy is recommended when feasible. Dose regimens for definitive and postoperative radiotherapy are detailed in this article, as well as the selection and delineation of tumour and lymph node target volumes.

Translated title of the contribution	Radiothérapie des cancers du larynx
Original language	English
Pages (from-to)	206-212
Number of pages	7
Journal	Cancer/Radiotherapie
Volume	26
Issue number	1-2
DOIs	https://doi.org/10.1016/j.canrad.2021.09.004
Publication status	Published - 1 Feb 2022

Keywords

Delineation
Dose
Indication
Intensity-modulated radiotherapy
Larynx cancer
Recommendations
Société française de radiothérapie oncologique

Access to Document

10.1016/j.canrad.2021.09.004

Cite this

@article{0bc8ab5b4a2349c2a34b8db6432de4ae,

title = "Radiotherapy for laryngeal cancers",

abstract = "We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensity modulated radiotherapy is the standard of care radiotherapy for the management of laryngeal cancers. Early stage T1 or T2 tumours can be treated either by radiotherapy or conservative surgery. For tumours requiring total laryngectomy (T2 or T3), an organ preservation strategy by either induction chemotherapy followed by radiotherapy or chemoradiotherapy with cisplatin is recommended. For T4 tumours, a total laryngectomy followed by radiotherapy is recommended when feasible. Dose regimens for definitive and postoperative radiotherapy are detailed in this article, as well as the selection and delineation of tumour and lymph node target volumes.",

keywords = "Delineation, Dose, Indication, Intensity-modulated radiotherapy, Larynx cancer, Recommendations, Soci{\'e}t{\'e} fran{\c c}aise de radioth{\'e}rapie oncologique",

author = "J. Biau and Y. Pointreau and P. Blanchard and C. Khampan and P. Giraud and M. Lapeyre and P. Maingon",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2022",

month = feb,

day = "1",

doi = "10.1016/j.canrad.2021.09.004",

language = "English",

volume = "26",

pages = "206--212",

journal = "Cancer/Radiotherapie",

issn = "1278-3218",

number = "1-2",

}

TY - JOUR

T1 - Radiotherapy for laryngeal cancers

AU - Biau, J.

AU - Pointreau, Y.

AU - Blanchard, P.

AU - Khampan, C.

AU - Giraud, P.

AU - Lapeyre, M.

AU - Maingon, P.

PY - 2022/2/1

Y1 - 2022/2/1

N2 - We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensity modulated radiotherapy is the standard of care radiotherapy for the management of laryngeal cancers. Early stage T1 or T2 tumours can be treated either by radiotherapy or conservative surgery. For tumours requiring total laryngectomy (T2 or T3), an organ preservation strategy by either induction chemotherapy followed by radiotherapy or chemoradiotherapy with cisplatin is recommended. For T4 tumours, a total laryngectomy followed by radiotherapy is recommended when feasible. Dose regimens for definitive and postoperative radiotherapy are detailed in this article, as well as the selection and delineation of tumour and lymph node target volumes.

AB - We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensity modulated radiotherapy is the standard of care radiotherapy for the management of laryngeal cancers. Early stage T1 or T2 tumours can be treated either by radiotherapy or conservative surgery. For tumours requiring total laryngectomy (T2 or T3), an organ preservation strategy by either induction chemotherapy followed by radiotherapy or chemoradiotherapy with cisplatin is recommended. For T4 tumours, a total laryngectomy followed by radiotherapy is recommended when feasible. Dose regimens for definitive and postoperative radiotherapy are detailed in this article, as well as the selection and delineation of tumour and lymph node target volumes.

KW - Delineation

KW - Dose

KW - Indication

KW - Intensity-modulated radiotherapy

KW - Larynx cancer

KW - Recommendations

KW - Société française de radiothérapie oncologique

UR - http://www.scopus.com/inward/record.url?scp=85124181283&partnerID=8YFLogxK

U2 - 10.1016/j.canrad.2021.09.004

DO - 10.1016/j.canrad.2021.09.004

M3 - Article

C2 - 34953705

AN - SCOPUS:85124181283

SN - 1278-3218

VL - 26

SP - 206

EP - 212

JO - Cancer/Radiotherapie

JF - Cancer/Radiotherapie

IS - 1-2

ER -

Radiotherapy for laryngeal cancers

Abstract

Keywords

Access to Document

Other files and links

Cite this